ADRB1 and stroke disorder: Likewise, in “instrument validation” analyses for ADRB1, our inability to recapitulate known effects of ADRB1 inhibition (via beta blockers) on stroke risk could reflect the aforementioned inability to account for blood pressure medication users in the stroke datasets analyzed.